Literature DB >> 17498736

Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy.

Mariko Tatsuguchi1, Hee Young Seok, Thomas E Callis, J Michael Thomson, Jian-Fu Chen, Martin Newman, Mauricio Rojas, Scott M Hammond, Da-Zhi Wang.   

Abstract

MicroRNAs (miRNAs) are a recently discovered class of approximately 22-nucleotide regulatory RNAs that post-transcriptionally regulate gene expression. We have recently demonstrated that muscle-specific miRNAs miR-1 and miR-133 play an important role in modulating muscle proliferation and differentiation. Here, we investigate the involvement of miRNAs in cardiac hypertrophy. We analyzed the global expression of miRNAs in agonist-induced hypertrophic cardiomyocytes as well as in pressure overload-induced hypertrophic hearts and found the miRNA expression profile altered in those hypertrophic conditions. We further show that inhibition of endogenous miR-21 or miR-18b augments hypertrophic growth. Conversely, introduction of functional miR-21 or miR-18b into cardiomyocytes represses myocyte hypertrophy. Together, our studies point to miRNAs as critical regulators of cardiac hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17498736      PMCID: PMC1934409          DOI: 10.1016/j.yjmcc.2007.04.004

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  16 in total

1.  Asymmetry in the assembly of the RNAi enzyme complex.

Authors:  Dianne S Schwarz; György Hutvágner; Tingting Du; Zuoshang Xu; Neil Aronin; Phillip D Zamore
Journal:  Cell       Date:  2003-10-17       Impact factor: 41.582

2.  Functional siRNAs and miRNAs exhibit strand bias.

Authors:  Anastasia Khvorova; Angela Reynolds; Sumedha D Jayasena
Journal:  Cell       Date:  2003-10-17       Impact factor: 41.582

Review 3.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

4.  MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development.

Authors:  Paul L Boutz; Geetanjali Chawla; Peter Stoilov; Douglas L Black
Journal:  Genes Dev       Date:  2007-01-01       Impact factor: 11.361

5.  Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis.

Authors:  Yong Zhao; Eva Samal; Deepak Srivastava
Journal:  Nature       Date:  2005-07-14       Impact factor: 49.962

6.  A custom microarray platform for analysis of microRNA gene expression.

Authors:  J Michael Thomson; Joel Parker; Charles M Perou; Scott M Hammond
Journal:  Nat Methods       Date:  2004-09-29       Impact factor: 28.547

7.  A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure.

Authors:  Eva van Rooij; Lillian B Sutherland; Ning Liu; Andrew H Williams; John McAnally; Robert D Gerard; James A Richardson; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-15       Impact factor: 11.205

8.  Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy.

Authors:  R L Nicol; N Frey; G Pearson; M Cobb; J Richardson; E N Olson
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

9.  Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy.

Authors:  H A Rockman; R S Ross; A N Harris; K U Knowlton; M E Steinhelper; L J Field; J Ross; K R Chien
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

10.  Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis.

Authors:  Angie M Cheng; Mike W Byrom; Jeffrey Shelton; Lance P Ford
Journal:  Nucleic Acids Res       Date:  2005-03-01       Impact factor: 16.971

View more
  186 in total

Review 1.  Micro-RNAs and breast cancer.

Authors:  John Le Quesne; Carlos Caldas
Journal:  Mol Oncol       Date:  2010-04-28       Impact factor: 6.603

2.  Determination of miRNA targets in skeletal muscle cells.

Authors:  Zhan-Peng Huang; Ramón Espinoza-Lewis; Da-Zhi Wang
Journal:  Methods Mol Biol       Date:  2012

Review 3.  microRNAs in heart disease: putative novel therapeutic targets?

Authors:  Gianluigi Condorelli; Michael V G Latronico; Gerald W Dorn
Journal:  Eur Heart J       Date:  2010-01-29       Impact factor: 29.983

Review 4.  MicroRNAs challenge the status quo of therapeutic targeting.

Authors:  Danish Sayed; Shweta Rane; Maha Abdellatif
Journal:  J Cardiovasc Transl Res       Date:  2008-09-09       Impact factor: 4.132

5.  The magic and mystery of miR-21.

Authors:  Edward E Morrisey
Journal:  J Clin Invest       Date:  2010-10-18       Impact factor: 14.808

6.  Developmental microRNA expression profiling of murine embryonic orofacial tissue.

Authors:  Partha Mukhopadhyay; Guy Brock; Vasyl Pihur; Cynthia Webb; M Michele Pisano; Robert M Greene
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-07

7.  Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins.

Authors:  Terry S Elton; Sarah E Sansom; Mickey M Martin
Journal:  RNA Biol       Date:  2010-09-01       Impact factor: 4.652

8.  Application of microRNA in cardiac and skeletal muscle disease gene therapy.

Authors:  Zhan-Peng Huang; Ronald L Neppl; Da-Zhi Wang
Journal:  Methods Mol Biol       Date:  2011

9.  Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support.

Authors:  Scot J Matkovich; Derek J Van Booven; Keith A Youker; Guillermo Torre-Amione; Abhinav Diwan; William H Eschenbacher; Lisa E Dorn; Mark A Watson; Kenneth B Margulies; Gerald W Dorn
Journal:  Circulation       Date:  2009-02-23       Impact factor: 29.690

Review 10.  MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine.

Authors:  V Sala; S Bergerone; S Gatti; S Gallo; A Ponzetto; C Ponzetto; T Crepaldi
Journal:  Cell Mol Life Sci       Date:  2013-11-12       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.